Prevalence of and factors associated with nonadherence to antipsychotic drugs in patients with schizophrenia

被引：0
|
作者：
Suttajit, S. [1 ]
Pilakanta, S. [1 ]
机构：
[1] Chiang Mai Univ, Dept Psychiat, Chiang Mai 50000, Thailand
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D O I：
10.1016/S0924-977X(10)70694-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S471 / S472
页数：2
相关论文
共 50 条
  • [41] Nonadherence to antipsychotic treatment in patients with schizophrenic disorders
    Svestka, Jaromir
    Bitter, Istvan
    NEUROENDOCRINOLOGY LETTERS, 2007, 28 : 95 - 116
  • [42] Akathisia Among Patients Undergoing Antipsychotic Therapy: Prevalence, Associated Factors, and Psychiatric Impact
    Jouini, Lamia
    Ouali, Uta
    Ouanes, Sami
    Ben Djebara, Mouna
    Nacef, Fethi
    Gouider, Riadh
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (04) : 89 - 94
  • [43] ANTIPSYCHOTIC-DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA
    CARLSSON, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (02): : 164 - 173
  • [44] Cognition, schizophrenia, and the atypical antipsychotic drugs
    Meltzer, HY
    Park, S
    Kessler, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) : 13591 - 13593
  • [45] Antipsychotic drugs for relapse prevention in schizophrenia
    Messori, Andrea
    Maratea, Dario
    Fadda, Valeria
    Trippoli, Sabrina
    LANCET, 2012, 380 (9847): : 1055 - 1056
  • [46] Atypical antipsychotic drugs in the treatment of schizophrenia
    Meltzer, HY
    NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 86 - 86
  • [47] Antipsychotic drugs, dopamine receptors, and schizophrenia
    Seeman, P
    CLINICAL NEUROSCIENCE RESEARCH, 2001, 1 (1-2) : 53 - 60
  • [48] Maintenance treatment with antipsychotic drugs for schizophrenia
    Leucht, Stefan
    Tardy, Magdolna
    Komossa, Katja
    Heres, Stephan
    Kissling, Werner
    Davis, John M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05):
  • [49] Atypical antipsychotic drugs in the treatment of schizophrenia
    Degner, D
    Rüther, E
    NERVENHEILKUNDE, 1998, 17 (10) : 472 - 479
  • [50] Schizophrenia, antipsychotic drugs, and cardiovascular disease
    Glassman, AH
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 5 - 10
12345